Exascale computing will make a significant difference to many aspects of our healthcare system. It will help researchers and providers to accelerate drug discovery and design advanced diagnostic solutions.

The recent Covid-19 pandemic has shown us just how important new drugs and vaccines are for our survival. But the current state of drug development is a lengthy, expensive process. The pharmaceutical industry is investing in high-performance computing, artificial intelligence, cloud computing and big data to reduce the time and cost of developing new drugs.

Further, medical research has become a big data computational problem. With the advanced power of exascale-class systems, a whole range of new treatments and technologies, generally called precision medicine or personalised medicine, promises a future in which treatment options for a range of diseases and conditions will be specifically targeted to the individual genome and health condition.